BioSpace News Archive

Health Care Service Corporation (HCSC), the nation’s largest customer-owned health insurer, today announced the departure of President and CEO Paula Steiner, who led the organization since 2016.

Health Catalyst, Inc., a leading provider of data and analytics technology and services to healthcare organizations, announced the pricing of its initial public offering of 7,000,000 shares of its common stock at a price to the public of $26.00 per share for total gross proceeds of $182.0 million.

Innovent Biologics, Inc. announced that the first patient has been dosed in ORIENT-31, a trial that evaluates Tyvyt®, a fully human anti-programmed cell death protein 1 (anti-PD-1) monoclonal antibody co-developed with Eli Lilly and Company, and IBI305, a recombinant humanized anti-vascular endothelial growth factor (anti-VEGF) monoclonal antibody

Castle Biosciences, Inc. announced the pricing of its initial public offering of 4,000,000 shares of its common stock at a price to the public of $16.00 per share.

An Image Survey of the Japanese Yogurt Market from the Perspective of Non-Japanese Consumers

BAQSIMI is expected to be available in U.S. pharmacies within one month

Kaiser Permanente will open a new five-story, state-of-the-art multi-specialty medical center in Woodbridge, Va.

Health Canada is advising consumers that it has seized three unauthorized eye health products—Digi Eye, Kobayashi Aibon/Eyebon Eyewash and Sante FX Neo―from a Glorious Cosmetics store in Edmonton, Alberta because they may pose serious health risks.

A new molecular mechanism discovered by UT Southwestern researchers indicates that drugs currently used to treat less than 10 percent of breast cancer patients could have broader effectiveness in treating all cancers where the drugs are used, including ovarian and prostate cancers.

The use of computed tomography (CT) scans during pregnancy — which exposes mothers and fetuses to ionizing radiation — has increased significantly over 21 years in the United States and Ontario, Canada